Hainan Zhang

4.3k total citations
112 papers, 2.0k citations indexed

About

Hainan Zhang is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hainan Zhang has authored 112 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 27 papers in Neurology and 20 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hainan Zhang's work include Parkinson's Disease Mechanisms and Treatments (17 papers), CRISPR and Genetic Engineering (12 papers) and Insect Resistance and Genetics (10 papers). Hainan Zhang is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (17 papers), CRISPR and Genetic Engineering (12 papers) and Insect Resistance and Genetics (10 papers). Hainan Zhang collaborates with scholars based in China, United States and France. Hainan Zhang's co-authors include Chunyu Wang, Lixia Qin, Beisha Tang, Zhiping Hu, Jifeng Guo, Jieqiong Tan, Sheng‐ce Tao, Shujuan Guo, Zhaojun Han and Jiasheng Chen and has published in prestigious journals such as Nature Communications, The EMBO Journal and Nature Methods.

In The Last Decade

Hainan Zhang

104 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hainan Zhang China 25 1.1k 334 259 230 205 112 2.0k
Ping Wu United States 28 1.1k 1.0× 353 1.1× 455 1.8× 319 1.4× 515 2.5× 78 2.8k
Morven Graham United States 25 2.0k 1.8× 128 0.4× 99 0.4× 306 1.3× 207 1.0× 39 3.1k
TuKiet T. Lam United States 29 1.6k 1.4× 136 0.4× 201 0.8× 285 1.2× 323 1.6× 113 3.0k
Juri Katchanov Germany 20 499 0.4× 148 0.4× 170 0.7× 384 1.7× 235 1.1× 50 1.8k
Hong‐Lin Su Taiwan 25 956 0.9× 98 0.3× 214 0.8× 224 1.0× 174 0.8× 58 2.0k
Manoj K. Mishra United States 40 1.6k 1.4× 265 0.8× 439 1.7× 323 1.4× 310 1.5× 84 4.5k
Kazuma Noguchi Japan 25 536 0.5× 77 0.2× 622 2.4× 411 1.8× 249 1.2× 122 2.7k
Paweł Ciborowski United States 32 1.2k 1.1× 431 1.3× 351 1.4× 441 1.9× 387 1.9× 95 3.3k
Aadra P. Bhatt United States 24 1.3k 1.2× 63 0.2× 225 0.9× 290 1.3× 128 0.6× 48 2.2k

Countries citing papers authored by Hainan Zhang

Since Specialization
Citations

This map shows the geographic impact of Hainan Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hainan Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hainan Zhang more than expected).

Fields of papers citing papers by Hainan Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hainan Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hainan Zhang. The network helps show where Hainan Zhang may publish in the future.

Co-authorship network of co-authors of Hainan Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Hainan Zhang. A scholar is included among the top collaborators of Hainan Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hainan Zhang. Hainan Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Haoxiang, Yi Xiang, Hainan Zhang, et al.. (2025). A survey on Quality-Diversity optimization: Approaches, applications, and challenges. Swarm and Evolutionary Computation. 100. 102240–102240.
2.
Chen, Luying, Hainan Zhang, & Xiaofeng Sui. (2025). Bio-based cellulose aerogels with liquid absorption and retention capability for sustainable personal hygiene applications. International Journal of Biological Macromolecules. 327(Pt 2). 147551–147551.
3.
Qiu, Yue, Wei Wang, Hainan Zhang, et al.. (2025). Prolonged versus short-term infusion of meropenem for the treatment of sepsis: a systematic review and meta-analysis. International Journal of Surgery. 111(10). 7213–7221.
4.
Lv, Lingling, Hainan Zhang, Jieqiong Tan, & Chunyu Wang. (2025). Neuroprotective role and mechanistic insights of DJ-1 dimerization in Parkinson’s disease. Cell Communication and Signaling. 23(1). 129–129. 5 indexed citations
5.
Li, Guoling, Xue Dong, Jiamin Luo, et al.. (2024). Engineering TadA ortholog-derived cytosine base editor without motif preference and adenosine activity limitation. Nature Communications. 15(1). 8090–8090. 6 indexed citations
6.
Zhang, Qi, et al.. (2024). Knockdown of tyrosine hydroxylase gene affects larval survival, pupation and adult eclosion in Plagiodera versicolora . Insect Molecular Biology. 34(2). 239–248. 1 indexed citations
7.
Luo, Bohan, Hainan Zhang, & Lixia Qin. (2023). Case report: Reversible encephalopathy caused by dyskinesia-hyperpyrexia syndrome. Frontiers in Neurology. 14. 1234974–1234974. 1 indexed citations
8.
Tong, Huawei, Nana Liu, Yinghui Wei, et al.. (2023). Programmable deaminase-free base editors for G-to-Y conversion by engineered glycosylase. National Science Review. 10(8). nwad143–nwad143. 45 indexed citations
9.
Lv, Lingling, Weiqian Yan, Hainan Zhang, et al.. (2022). MicroRNA-409-3p Targeting at ATXN3 Reduces the Apoptosis of Dopamine Neurons Based on the Profile of miRNAs in the Cerebrospinal Fluid of Early Parkinson’s Disease. Frontiers in Cell and Developmental Biology. 9. 755254–755254. 8 indexed citations
10.
Yan, Weiqian, Zhiping Hu, Yingchi Zhang, Xiaomei Wu, & Hainan Zhang. (2022). Case Report: Metagenomic Next-Generation Sequencing for Diagnosis of Human Encephalitis and Endophthalmitis Caused by Pseudorabies Virus. Frontiers in Medicine. 8. 753988–753988. 20 indexed citations
11.
Jin, Tao, Xiaoliu Shi, Lingling Lv, et al.. (2020). Preliminary Findings on Proline-Rich Protein 14 as a Diagnostic Biomarker for Parkinson’s Disease. NeuroMolecular Medicine. 23(2). 285–291. 7 indexed citations
12.
He, Miao, et al.. (2020). Balance and coordination training for patients with genetic degenerative ataxia: a systematic review. Journal of Neurology. 268(10). 3690–3705. 12 indexed citations
13.
Qi, Huan, Ming‐liang Ma, Chuansheng Hu, et al.. (2020). Antibody Binding Epitope Mapping (AbMap) of Hundred Antibodies in a Single Run. Molecular & Cellular Proteomics. 20. 100059–100059. 38 indexed citations
14.
Xu, Zhaowei, Hainan Zhang, Xingrun Zhang, et al.. (2019). Interplay between the bacterial protein deacetylase CobB and the second messenger c‐di‐ GMP. The EMBO Journal. 38(18). e100948–e100948. 32 indexed citations
15.
Zheng, Qian, Jifeng Guo, Jieqiong Tan, et al.. (2017). Hsp70 participates in PINK1-mediated mitophagy by regulating the stability of PINK1. Neuroscience Letters. 662. 264–270. 24 indexed citations
17.
Wang, Chunyu, Qian Xu, Ling Weng, et al.. (2011). Genetic variations of Omi/HTRA2 in Chinese patients with Parkinson's disease. Brain Research. 1385. 293–297. 16 indexed citations
18.
Zhang, Xuewei, Hainan Zhang, Bing Liao, et al.. (2011). Mutation analysis of PINK1 gene in patients with early-onset Parkinsonism.. PubMed. 36(6). 490–7. 3 indexed citations
19.
Xi, Huang, Rong Fan, Hainan Zhang, et al.. (2010). Bioethnopharmaceutical analytical pharmacology: a strategy for elucidating ethnoherbal absorbed bioactive compounds.. Zhongcaoyao. 41(3). 337–339. 1 indexed citations
20.
Hu, Zhiping, et al.. (2005). Acute Dystonia Induced by Lamivudine. Clinical Neuropharmacology. 28(4). 193–194. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026